Clinical Trial Update: Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This entry reports on a Phase 2 trial of exemestane plus goserelin for premenopausal women with metastatic breast cancer. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• Zoladex (goserelin)

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED